… some of its top-selling medicines, including cancer immunotherapy Opdivo (nivolumab) and … due to generic competition for drugs like Revlimid (lenalidomide) and Abraxane (nab … the recent approval by the FDA of its new schizophrenia therapy …

… immuno-oncology (Opdivo) and cardiovascular treatments (Eliquis) ensures sustained pricing … data expected for next-generation treatments targeting autoimmune diseases. Future … loss of exclusivity for critical drugs like Revlimid, Opdivo, and Eliquis presents …

… -grossing products, the multiple myeloma drug Revlimid. But it’s also bracing … Eliquis to heart drug Camzyos and anti-inflammatory treatment Sotyktu — topped consensus … prospects for cancer and neurological conditions, and Karuna’s medicine, Cobenfy, has …

… .S. approval of Cobenfy, a treatment for schizophrenia in adults, which … increased competition for its older cancer treatments, including Revlimid, Pomalyst, Sprycel, and Abraxane … from key drugs like the blood thinner Eliquis and cancer immunotherapy Opdivo …

… of its biggest moneymakers—cancer treatment Opdivo and blood thinner … of the first 10 drugs affected by government negotiations … exclusivity (LOE) of blood cancer medicine Revlimid. The cuts also come … for the game-changing treatment. “The significant ramp- …

… believe its portfolio of growth drugs including Cobenfy can help … is expecting to two trial readouts this year that … expects at least one clinical trial readout for Cobenfy in … among them is that blood cancer treatment Revlimid is seeing increased generic …

… as in the clinical trials, suggest that the overall … another trial looking head-to-head iberdomide versus Revlimid, which … and there are multiple treatment options available. We remain … Vice President, Chief Medical Officer, Drug Development Chris Shibutani -- …

… That includes four drugs for different cancers: Revlimid, Pomalyst, Sprycel and … for the quarter.  The pharmaceutical giant's revenue … the drug goes into effect for certain Medicare patients … .10 billion for the treatment, according to StreetAccount.  …

… medicines, including the blood thinner Eliquis and the cancer drugs Revlimid … -focused biotech Seagen for … trial showed. The vaccine, developed by scientists at Dana-Farber Cancer … vaccines to change the course of certain cancer types, but larger, longer trials …

… is planning three Phase III trials of the asset, which was … legacy products like Eliquis and Revlimid and growth products like Opdivo …